166Ho radioembolization is feasible and safe1 for the treatment of patients with unresectable and chemorefractory liver metastases and enables image-guided treatment.
Featured product: QuiremSpheres® Microspheres
Giammaria Fiorentini, Donatella Sarti, Riccardo Carandina, Luca Mulazzani, Cinzia Mincarelli, Roberto Candelari, Renato Argirò, Caterina Fiorentini & Camillo Aliberti
Featured product: LifePearl® Drug Elutable Microspheres
Radioembolization with 166Ho microspheres induced a tumor response with an acceptable toxicity profile in patients with liver metastases.
This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public
This is HCP only content